2006D-0383
  

  
 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases

  


  

  

  


  

  


  

  


  

  


  

  


  

  
FDA Comment Number : 
  

  
EC3670
  



  

  
Submitter : 
  

  
Mr. Michael O'Neill
  

  
Date & Time: 
  

  
12/19/2006 09:12:39
  



  

  
Organization : 
  

  
N/A
  



  

  
Category : 
  

  
Individual Consumer
  



  

  
Issue Areas/Comments 
  


  

  


  

  
GENERAL
  


  

  



  

  
GENERAL
  


  

  



  

  
I urgently request the FDA discontinue the practice of using aborted fetal cell line products.